|
|
Cat. No |
Model |
Description |
Unit |
Price (VATº°µµ) |
³³±â |
Àç°í |
DataSheet |
ÁÖ¹®/°ßÀû |
LCA-50-11265 |
416358-0.5 |
Anti-8-Isoprostane, Sepharose¢â Conjugated Column/4 ml column/ |
1/EA |
|
|
|
|
¹®ÀÇ |
|
|
|
|
|
|
Subject
|
Anti-8-Isoprostane, Sepharose¢â Conjugated Column |
Description
|
4 ml column / |
Clonality
|
Poly |
Company
|
Cayman Chemical |
Application
|
Affinity purification |
Conjugation
|
|
Immunogen
|
8-Isoprostane |
Contents
|
Traditional purification of urine and plasma samples prior to measurement by EIA has required the use of reverse phase C-18 columns and various organic solvents. As this method relies upon polarity for separation, the final purified product is a non-specific mixture of many compounds. Further purification by TLC or HPLC is then required to isolate a single product. As an alternative, affinity chromatography provides a specific, reliable, and convenient means of purification for a variety of sample types. Cayman Chemical has developed an affinity column for the purification of 8-isoprostane (8-iso PGF2α) from urine and plasma samples. The affinity column can be regenerated by following a simple washing procedure. 8-Isoprostane is a potent pulmonary and renal vasoconstrictor and has been implicated as a causative mediator of hepatorenal syndrome and pulmonary oxygen toxicity. It has also been proposed as a marker of antioxidant activity. Cayman Chemical\'s 8-Isoprostane EIA Kit (Catalog No. 516351) is a highly sensitive and accurate assay, and our affinity purification reagents improve it even more. SEPHAROSE is a trademark of Ge Healthcare companies |
|
|
|
|